T6755 |
AM1241
|
444912-48-5
|
98.72%
|
|
AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.
|
T19094 |
2,3-Butanediol
|
513-85-9
|
98.64%
|
|
2,3-Butanediol is a butanediol derived from the bioconversion of natural resources which has great potential for diverse industries, including chemical, cosmetic...
|
T29930 |
AM-1235
|
335161-27-8
|
98.62%
|
|
AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
|
T7316 |
LY2828360
|
1231220-79-3
|
98.61%
|
|
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, ...
|
T41230 |
CB 65
|
913534-05-1
|
98.39%
|
|
CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.
|
T28468 |
PSNCBAM-1
|
877202-74-9
|
98.18%
|
|
PSNCBAM-1 (PSNCBAM 1) is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies....
|
T37075 |
CB2R PAM
|
2244579-87-9
|
98.17%
|
|
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive mutational modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]G...
|
T22009 |
CB2 receptor agonist 2
|
1314230-75-5
|
98.07%
|
|
CB2 receptor agonist 2 (ZINC72105556) is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high a...
|
T1519L |
Rimonabant
|
168273-06-1
|
98%
|
|
Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its m...
|
T2635 |
Org 27569
|
868273-06-7
|
98%
|
|
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and e...
|
T5996 |
CB1-IN-1
|
1429239-98-4
|
98%
|
|
CB1-IN-1 (DBPR211) is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 nM and 21 nM,respectively.
|
T3699 |
Bay 59-3074
|
406205-74-1
|
98%
|
|
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic a...
|
T7375 |
A-836339
|
959746-77-1
|
98%
|
|
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 recep...
|
T3S0738 |
Yangonin
|
500-62-9
|
98%
|
|
Yangonin (Y100550) is a novel CB receptor ligand, it exhibits affinity for the human recombinant CB receptor. Yangonin (Y100550) could be a valuable candidate fo...
|
T1915 |
AM251
|
183232-66-8
|
97.88%
|
|
AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity over CB2 receptors; also effective GPR55 agonist (EC50: 39 ...
|
T9114 |
β-Caryophyllene
|
87-44-5
|
97.31%
|
|
β-Caryophyllene ((-)-(E)-Caryophyllene) acts as an CB2 receptor agonist.
|
T14302 |
Olorinab
|
1268881-20-4
|
97.13%
|
|
Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.
|
TN5131 |
Tetrahydrocannabivarin
|
31262-37-0
|
96.30%
|
|
Tetrahydrocannabivarin (CRM) is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimu...
|
T24771 |
SCH-336
|
447459-51-0
|
95.01%
|
|
SCH-336 is a CB2 receptor agonist (Ki-1.8 nM, EC50-2 nM) with effective, selective, and oral activity. SCH-336 is also bioactive against CB1 receptor, and is 100...
|
T8511 |
TM38837
|
1253641-65-4
|
100%
|
|
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
|